Policy and Advocacy
How NIH Funding Fuels Innovation and Economic Growth
Continued investment in the NIH is essential to fighting current and emerging health threats and to ensuring the U.S. remains a global leader in medical innovation.
Your Source for HIV Data
amfAR maintains a series of free interactive databases to inform policymakers, public health officials, advocates, researchers, and other stakeholders about key aspects of the evolving U.S. and global HIV epidemics. These essential resources provide comprehensive data on global HIV programming/funding, key populations, the opioid epidemic, COVID-19, and the U.S. Ending the Epidemic plan.
FDA Approves Lenacapavir for HIV Pre-Exposure Prophylaxis
The FDA-approved lenacapavir for PrEP holds the potential to dramatically reduce HIV infections with its adherence-friendly twice-annual injection.
Unprecedented Cuts Across Health and Human Services Put Lives in Peril
More than one million people living with HIV in the U.S. rely on services that can only be provided by a fully funded HIV response.
Cuts to the CDC’s Division of HIV Prevention Will Lead to Dramatic Rise in Infections, Deaths, and Costs
Without funding, there will be a loss of momentum in reducing HIV cases, and the nation’s epidemic will worsen significantly.